Role of prefrontal dopaminergic neurotransmission in glucocorticoid receptor-mediated modulation of methamphetamine-induced hyperactivity

Synapse

Volumn 63, Issue 1, 2009, Pages 7-14

  Yukio, A G O ^a   Arikawa, Shinsuke ^a   Yata, Miyuki ^a   Yano, Koji ^a   Michikazu, A B E ^b   Takuma, Kazuhiro ^a   Matsuda, Toshio ^a,c  

^a OSAKA UNIVERSITY   (Japan)

^b MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adrenalectomy; Dopamine (DA); Glucocorticoid receptor antagonist; Hyperactivity; Methamphetamine (METH); Prefrontal cortex

Indexed keywords

CORTICOSTERONE; DOPAMINE; GLUCOCORTICOID RECEPTOR; GLUCOCORTICOID RECEPTOR ANTAGONIST; METHAMPHETAMINE; RU 43044; SEROTONIN; UNCLASSIFIED DRUG;

ADRENALECTOMY; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR CHANGE; CORTICOSTERONE BLOOD LEVEL; DOPAMINERGIC TRANSMISSION; HYPERACTIVITY; LOCOMOTION; MALE; MOUSE; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL;

ADRENALECTOMY; ANIMALS; DOPAMINE; HYDROXYCORTICOSTEROIDS; HYPERKINESIS; MALE; METHAMPHETAMINE; MICE; MOTOR ACTIVITY; PREFRONTAL CORTEX; RECEPTORS, GLUCOCORTICOID; SYNAPTIC TRANSMISSION;

EID: 58149484069     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20575     Document Type: Article

References (31)

1. 1A receptor-mediated dopamine release in vivo in the frontal cortex of mice. J Neurochem 83:353-359.
2. 1A receptors of the in vivo release of 5-HT and DA in mouse frontal cortex. Neuropharmacology 45:1050-1056.
3. Ago Y, Nakamura S, Baba A, Matsuda T. 2005. Sulpiride in combination with fluvoxamine increases in vivo dopamine release selectively in rat prefrontal cortex. Neuropsychopharmacology 30:43-51.
4. 1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice. Neuropharmacology 51:914-922.
5. Ago Y, Nakamura S, Kajita N, Uda M, Hashimoto H, Baba A, Mat-suda T. 2007. Ritanserin reverses repeated methamphetamine-induced behavioral and neurochemical sensitization in mice. Synapse 61:757-763.
6. Barrot M, Marinelli M, Abrous DN, Rougé-Pont F, Le Moal M, Piazza PV. 2000. The dopaminergic hyper-responsiveness of the shell of the nucleus accumbens is hormone-dependent. Eur J Neu-rosci 12:973-979.
7. Cador M, Dulluc J, Mormède P. 1993. Modulation of the locomotor response to amphetamine by corticosterone. Neuroscience 56:981-988.
8. Claustre Y, Rivy JP, Dennis T, Scatton B. 1986. Pharmacological studies on stress-induced increase in frontal cortical dopamine metabolism in the rat. J Pharmacol Exp Ther 238:693-700.
9. Dazzi L, Serra M, Spiga F, Pisu MG, Jentsch JD, Biggio G. 2001. Prevention of the stress-induced increase in frontal cortical dopamine efflux of freely moving rats by long-term treatment with antidepressant drugs. Eur Neuropsychopharmacol 11:343-349.
10. Deroche V, Piazza PV, Maccari S, Le Moal M, Simon H. 1992. Repeated corticosterone administration sensitizes the locomotor response to amphetamine. Brain Res 584:309-313.
11. De Vries TJ, Schoffelmeer AN, Tjon GH, Nestby P, Mulder AH, Van-derschuren LJ. 1996. Mifepristone prevents the expression of long-term behavioral sensitization to amphetamine. Eur J Pharmacol 307:R3-R4.
12. Finlay JM, Zigmond MJ. 1997. The effects of stress on central dopaminergic neurons: Possible clinical implications. Neurochem Res 22:1387-1394.
13. Franklin KBJ, Paxinos G. 1997. The mouse brain in stereotaxic coordinates. San Diego: Academic Press.
14. Imperato A, Puglisi-Allegra S, Casolini P, Angelucci L. 1991. Changes in brain dopamine and acetylcholine release during and following stress are independent of the pituitary-adrenocortical axis. Brain Res 538:111-117.
15. Marinelli M, Piazza PV. 2002. Interaction between glucocorticoid hormones, stress and psychostimulant drugs. Eur J Neurosci 16: 387-394.
16. Marinelli M, Aouizerate B, Barrot M, Le Moal M, Piazza PV. 1998. Dopamine-dependent responses to morphine depend on glucocorticoid receptors. Proc Natl Acad Sci USA 95:7742-7747.
17. Mizoguchi K, Ishige A, Takeda S, Aburada M, Tabira T. 2004. Endogenous glucocorticoids are essential for maintaining prefrontal cortical cognitive function. J Neurosci 24:5492-5499.
18. Morgan BP, Swick AG, Hargrove DM, LaFlamme JA, Moynihan MS, Carroll RS, Martin KA, Lee E, Decosta D, Bordner J. 2002. Discovery of potent, nonsteroidal, and highly selective glucocorticoid receptor antagonists. J Med Chem 45:2417-2424.
19. Mormède P, Dulluc J, Cador M. 1994. Modulation of the locomotor response to amphetamine by corticosterone. Ann NY Acad Sci 746:394-397.
20. Morón JA, Brockington A, Wise RA, Rocha BA, Hope BT. 2002. Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: Evidence from knock-out mouse lines. J Neurosci 22:389-395.
21. Pauly JR, Robinson SF, Collins AC. 1993. Chronic corticosterone administration enhances behavioral sensitization to amphetamine in mice. Brain Res 620:195-202.
22. Piazza PV, Barrot M, Rougé-Pont F, Marinelli M, Maccari S, Abrous DN, Simon H, Le Moal M. 1996a. Suppression of glucocorticoid secretion and antipsychotic drugs has similar effects on the meso-limbic dopaminergic transmission. Proc Natl Acad Sci USA 93:15445-15450.
23. Piazza PV, Rougé-Pont F, Deroche V, Maccari S, Simon H, Le Moal M. 1996b. Glucocorticoids have state-dependent stimulant effects on the mesencephalic dopaminergic transmission. Proc Natl Acad Sci USA 93:8716-8720.
24. Rougé-Pont F, Deroche V, Le Moal M, Piazza PV. 1998. Individual differences in stress-induced dopamine release in the nucleus accumbens are influenced by corticosterone. Eur J Neurosci 10:3903-3907.
25. Shatnawi A, Tran T, Ratnam M. 2007. R5020 and RU486 act as progesterone receptor agonists to enhance Sp1/Sp4-dependent gene transcription by an indirect mechanism. Mol Endocrinol 21:635-650.
26. Thompson TL, Moss RL. 1995. In vivo stimulated dopamine release in the nucleus accumbens: Modulation by the prefrontal cortex. Brain Res 686:93-98.
27. Ugale RR, Mittal N, Hirani K, Chopde CT. 2004. Essentiality of central GABAergic neuroactive steroid allopregnano-lone for anticonvulsant action of fluoxetine against pentyle-netetrazole-induced seizures in mice. Brain Res 1023:102-111.
28. van den Buuse M, Morris M, Chavez C, Martin S, Wang J. 2004. Effect of adrenalectomy and corticosterone replacement on pre-
29. pulse inhibition and locomotor activity in mice. Br J Pharmacol 142:543-550.
30. Ventura R, Alcaro A, Cabib S, Conversi D, Mandolesi L, Puglisi-Allegra S. 2004. Dopamine in the medial prefrontal cortex controls genotype-dependent effects of amphetamine on mesoaccum-bens dopamine release and locomotion. Neuropsychopharmacology 29:72-80.
31. Webster NJ, Green S, Jin JR, Chambon P. 1988. The hormone-binding domains of the estrogen and glucocorticoid receptors contain an inducible transcription activation function. Cell 54:199-207.